Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and collateral circulation after revascularization in moyamoya disease
ChiCTR2200064976Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Moyamoya disease comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Formation of collateral circulation and Number of endothelial progenitor cells. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
Moyamoya disease
Beyond the preview
Go deeper on ChiCTR2200064976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064976.